About Us
Experience Matters
Gene editing technologies (eg. CRISPR-Cas, Base-editing) Synthetic Biology, Bioinformatics, Cell and Gene Therapy, non-viral delivery tech of therapeutics, Nanotech and Artificial Intelligence technologies (eg. Generative AI/ML) in Biotech & AgTech R&D are key areas of growth-opportunity in our wheelhouse of expertise and experience, which are poised to lead a global Bioeconomy in the 21st century.
We possess decades of experience in these key areas working for startup biotech to big pharma as co-founders and having key positions that led to expansion of global business objectives including M&A. Routine travel in US, Europe, Asia Pacific to annual conferences such as BIO, JPMorgan, BIO Europe and LSN RESI as well as on-site visits to partner our clients with various stakeholders in the global biopharma industry.
Experienced co-founder and entrepreneur having expanded offshore entities to US locations and expanded US operations abroad.
We develop corporate strategy from the ground floor of a seed funding stage startup through growth phase licensing & partnering executions to planning a successful exit strategy.
Large network of investors, biotech/pharma S&E and licensing exec partners. We can help you refine your business goals from conception and formation of the company, or find the right exit with a mature growth stage company.
“The journey of a thousand miles begins beneath one’s feet.” - Lau Tzu
Process
Our process is designed to empower your team with the tools they need to succeed.
Talk to us today about how we can support your growth and put you on a solid track to success.
Send us your information and submit a pitch deck.
E.O. Wilson on convergence of AI, Synthetic Biology, Robotics
"Synthetic Biology Will Radically Change the World"
Copyright © 2025 AGTC Ventures LLC - All Rights Reserved.
Take the first step to your business launch
Send us a message and PDF format pitch deck (if applicable). If you don't have one that's okay, that's what we're here for.